NOTA Laboratories, Inc.
HOME | nota-laboratories
Ann Arbor, United States · Founded 2015 · $9.3M raised
- Headquarters
- Ann Arbor, Michigan
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Website
- notalabs.com
- Total Funding
- $9.3M
- Last Round
- $4.3M Series AOct 2023
About
NOTA Laboratories is a biomedical R&D company focused on the therapeutic applications of inhaled nitric oxide (iNO). The company develops novel nitric oxide-based treatments leveraging NO's broad biological roles as an immune modulator, potent vasodilator, and antimicrobial agent. Its pipeline targets pulmonary hypertension, chronic airway infections (CF, COPD, sinusitis, tuberculosis), primary graft failure prevention in lung transplantation, antiviral therapy, and thrombosis prevention during extracorporeal circulation. NOTA Laboratories has received multiple SBIR/STTR grants from the NIH and holds partnerships with the University of Michigan.
Summary
NOTA Laboratories, Inc. is a Biotech company based in Ann Arbor, United States, founded in 2015. It has raised $9.3M in total, most recently a $4.3M Series A round in Oct 2023.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company